Exencial Wealth Advisors, LLC Revance Therapeutics, Inc. Transaction History

Exencial Wealth Advisors, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$18.36 - $35.27 $166,066 - $319,017	9,045 New	9,045 $291,000
Q3 2022 Nov 08, 2022	BUY	$14.33 - $28.47 $129,614 - $257,511	9,045 New	9,045 $244,000
Q4 2021 Feb 10, 2022	SELL	$12.46 - $27.87 $505,315 - $1.13 Million	-40,555 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$24.03 - $29.97 $25,832 - $32,217	-1,075 Reduced 2.58%	40,555 $1.13 Million
Q4 2020 Feb 11, 2021	BUY	$23.41 - $28.34 $342,628 - $414,784	14,636 Added 54.22%	41,630 $1.18 Million
Q3 2020 Nov 13, 2020	BUY	$23.23 - $34.3 $4,646 - $6,859	200 Added 0.75%	26,994 $679,000
Q2 2020 Aug 17, 2020	BUY	$12.6 - $26.55 $5,821 - $12,266	462 Added 1.75%	26,794 $654,000
Q1 2020 May 15, 2020	BUY	$12.46 - $27.81 $1,246 - $2,781	100 Added 0.38%	26,332 $390,000
Q4 2019 Feb 14, 2020	BUY	$11.66 - $20.15 $4,081 - $7,052	350 Added 1.35%	26,232 $426,000
Q3 2019 Nov 13, 2019	BUY	$10.22 - $14.5 $158,737 - $225,214	15,532 Added 150.07%	25,882 $336,000
Q1 2019 May 08, 2019	SELL	$15.4 - $20.39 $38,500 - $50,975	-2,500 Reduced 19.46%	10,350 $163,000
Q3 2018 Nov 05, 2018	SELL	$23.55 - $30.1 $68,153 - $87,109	-2,894 Reduced 18.38%	12,850 $319,000
Q2 2018 Aug 01, 2018	BUY	$27.45 - $33.35 $27,450 - $33,350	1,000 Added 6.78%	15,744 $432,000
Q1 2018 May 09, 2018	BUY	$29.15 - $37.4 $32,065 - $41,140	1,100 Added 8.06%	14,744 $454,000
Q4 2017 Feb 09, 2018	BUY	$24.55 - $36.3 $334,960 - $495,277	13,644	13,644 $488,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.